Background
Mini laparoscopy (ML) is an emerging minimally invasive technique that aims to improve upon standard laparoscopy in the areas of tissue trauma, pain and cosmesis. ML instruments are 3mm in diameter or less compared to traditional 5mm diameter laparoscopic instruments. The miniaturized instruments accommodate mini ports and small trocar incisions that aim to improve outcomes. The objective of this study was to determine if there was a difference in functionality between two novel ML i
Objective: The concept of reducing the number of transabdominal access ports has been criticized for violating basic tenets of traditional multiport laparoscopy. The potential benefits of natural orifice translumenal endoscopic surgery, reduced port surgery, and laparoendoscopic single-site surgery include decreased postoperative pain, improved cosmesis, less hernias and fewer wound-related complications. However, the technical challenges associated with these access methods have not been adequa
Introduction:
It has been well described that patient payer status and racial differences may account for disparities in treatment for benign biliary disease, resulting in lower rates of laparoscopic cholecystectomy and increased non-operative management. We conducted a retrospective chart review of patients who received cholecystectomy for benign biliary disease at an urban safety-net hospital. Our objective was to characterize the management of benign biliary disease in a population that may
BACKGROUND:
The monopolar “Bovie” instrument is ubiquitous. It is used by all surgical specialties on almost all surgical cases. The power delivered by the monopolar generator provides the end-user with a variety of settings to achieve different tissue effects, however patterns of use are unknown. The PURPOSE of this study is to determine the patterns with which surgeons use the monopolar instrument.
STUDY DESIGN:
We collected retrospective electronic data on consecutive activations of the
Background: Diabetes prevalence is expected to increase from 2.8% in 2000 to 4.8% in 2030. Point-of-Care (POC) Hemoglobin A1c (A1C) testing kits developed in 2008 and ADA guidelines from 2009 for diagnostic use of A1C made it plausible to use POC A1C kits for community-based diabetes screening and evaluation of known diabetic management in a developing country.
Methods: In 2009 & 2010, diabetes screening was performed in Gujarat, India at medical camps held during Muslim sermons led by Dawoo